Importer of Controlled Substances Application: Globyz Pharma, LLC; Correction
application · Notice · Notice of application; correction. · Published 2022-01-24 · 87 FR 3587
Document
Document number
2022-00852
Federal Register citation
87 FR 3587
Type
Notice
Action
Notice of application; correction.
Category
application
Publication date
2022-01-24
Party named
Globyz Pharma, LLC; Correction
Abstract
The Drug Enforcement Administration (DEA) published a document in the Federal Register on August 12, 2021, concerning a notice of application. The document indicated the approved drug code (1205-- Lisdexamfetamine) as a schedule I. The correct drug schedule should read schedule II.